Crohn's Disease Drug Market to Experience Dynamic Growth of 73% by 2013

Novel Biologic Agents Will Drive the Market, According to a New Study from

Decision Resources

Nov 02, 2004, 00:00 ET from Decision Resources, Inc.

    WALTHAM, Mass., Nov. 2 /PRNewswire/ -- Decision Resources, Inc., one of
 the world's leading research and advisory firms focusing on pharmaceutical and
 health care issues, forecasts that the Crohn's disease drug market will
 experience dynamic growth of 73% by 2013. According to the new Pharmacor study
 entitled Crohn's Disease, the growth will be a direct result of the launch of
 novel biologic agents into the market.
     "Several novel biologic agents in late-stage clinical development are
 expected to launch for the treatment of Crohn's disease in the next ten
 years," said Melissa G. Stolper, analyst at Decision Resources. "The launch of
 these emerging agents will expand the number of treatment options for patients
 with severe, refractory disease, and physicians will therefore be able to
 prescribe second- or third-line biologics for patients who fail to respond to
 a first-line biologic. The expanding percentage of patients who will be
 treated with biologics and the premium pricing of these new biologics will
 help drive composite 2013 sales for these emerging therapies to $843 milllion,
 a figure representing almost 50% of the overall Crohn's disease market in that
     About Crohn's Disease
     Crohn's disease is a chronic, relapsing/remitting inflammatory disease
 that predominantly affects the small and large intestines, including the
 rectum. In 2003, the diagnosed prevalent population in the seven major
 pharmaceutical markets (United States, France, Germany, Italy, Spain, United
 Kingdom, and Japan) totaled more than 550,000.
     About Pharmacor from Decision Resources
     Pharmacor is a unique family of studies that assesses a host of market-
 impacting factors and analyzes the commercial outlook for drugs in research
 and development.
     About Decision Resources
     Decision Resources, Inc., ( is a world
 leader in market research publications, advisory services, and consulting
 designed to help clients shape strategy, allocate resources, and master their
 chosen markets.
     All company, brand, or product names contained in this document may be
 trademarks or registered trademarks of their respective holders.
     For more information, contact:
      Elizabeth Marshall
      Decision Resources, Inc.

SOURCE Decision Resources, Inc.